House Bill 2020, introduced to Congress on Thursday, would finally remove cannabis from its current standing as a Schedule I narcotic, and reclassify it as Schedule III drug with an accepted medical value.

According to the DEA, Schedule III drugs are those with “a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.”

Current Schedule III substances include Tylenol with Codeine, ketamine and anabolic steroids.

The rescheduling bill is the brainchild of Republican Rep. Matt Gaetz and Democratic Rep. Darren Soto.

New Bipartisan Bill Would Reclassify Cannabis as Schedule III

House Bill 2020, introduced to Congress on Thursday, would finally remove cannabis from its current standing as a Schedule I narcotic, and reclassify it as Schedule III drug with an accepted medical value.

According to the DEA, Schedule III drugs are those with “a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.”

Current Schedule III substances include Tylenol with Codeine, ketamine and anabolic steroids.

The rescheduling bill is the brainchild of Republican Rep. Matt Gaetz and Democratic Rep. Darren Soto. The two Florida congressmen are hoping to open the door for expanded research into medical marijuana and create a legal framework that allows canna-businesses to do their banking the traditional way, instead of relying strictly on cash.

“I have supported cannabis reform as a state legislator, and I want to see the people that I fought for in my state have access to a legal, high-quality product that’s been well-researched,” Gaetz told the Cannabist.

And while Gaetz did have a part in passing CBD oil legalization while he was a Florida state legislator in…

Continue reading at MerryJane.com

About Merry Jane

is the definitive cannabis resource on culture, news, video, food and style dedicated to expressing a new cannabis mentality. Through exclusive content and relatable perspectives, MERRY JANE highlights the best of cannabis lifestyle while also offering vital, interactive tools to explore the new frontier of products, dispensaries and community.

Leave a Reply

Your email address will not be published. Required fields are marked *